Insights

Innovative Cancer Therapeutics Boundless Bio is pioneering ecDNA-targeted cancer treatments with promising candidates like BBI-940, a first-in-class orally bioavailable Kinesin degrader. This positions the company at the forefront of precision oncology, creating opportunities to collaborate on novel targeted therapies.

Strong Industry Presence With active participation in leading conferences such as AACR and Goldman Sachs Healthcare Summit, Boundless Bio demonstrates high visibility within the biotech and oncology communities, making them accessible for strategic partnerships and research collaborations.

Funding and Growth Potential Having secured around $100 million in funding and generating revenue between $25 million and $50 million, Boundless Bio shows substantial financial backing and growth trajectory, offering opportunities for investment, co-development, and joint ventures.

Specialized Scientific Focus Focus on ecDNA biology and the development of targeted degraders provides a unique selling point, opening potential sales channels for biotech firms, research institutions, and healthcare providers interested in cutting-edge cancer therapeutics and diagnostics.

Leadership and Talent With experienced executives such as CEO Zachary Hornby and new Chief Medical Officer Dr. Robert Doebele, Boundless Bio’s leadership indicates a solid foundation for rapid advancement and commercialization, creating opportunities for professional collaboration and sales of clinical services or research products.

Boundless Bio Tech Stack

Boundless Bio uses 8 technology products and services including Salesforce, MySQL, Microsoft Excel, and more. Explore Boundless Bio's tech stack below.

  • Salesforce
    Customer Relationship Management
  • MySQL
    Database
  • Microsoft Excel
    Editors
  • Font Awesome
    Font Scripts
  • Google Cloud Platform
    Infrastructure As A Service
  • SAP Maintenance, Repair, and Overhaul
    Operations
  • Microsoft Azure
    Platform As A Service
  • C++
    Programming Languages

Media & News

Boundless Bio's Email Address Formats

Boundless Bio uses at least 1 format(s):
Boundless Bio Email FormatsExamplePercentage
FLast@boundlessbio.comJDoe@boundlessbio.com
74%
Last@boundlessbio.comDoe@boundlessbio.com
24%
FirstLast@boundlessbio.comJohnDoe@boundlessbio.com
2%

Frequently Asked Questions

Where is Boundless Bio's headquarters located?

Minus sign iconPlus sign icon
Boundless Bio's main headquarters is located at 10955 Alexandria Way Suite 100 San Diego, California United States. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Boundless Bio's stock symbol?

Minus sign iconPlus sign icon
Boundless Bio is a publicly traded company; the company's stock symbol is BOLD.

What is Boundless Bio's official website and social media links?

Minus sign iconPlus sign icon
Boundless Bio's official website is boundlessbio.com and has social profiles on LinkedInCrunchbase.

What is Boundless Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Boundless Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Boundless Bio have currently?

Minus sign iconPlus sign icon
As of March 2026, Boundless Bio has approximately 48 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: R. C. D.Chief Financial Officer: J. R.Co-Founder: P. M.. Explore Boundless Bio's employee directory with LeadIQ.

What industry does Boundless Bio belong to?

Minus sign iconPlus sign icon
Boundless Bio operates in the Biotechnology Research industry.

What technology does Boundless Bio use?

Minus sign iconPlus sign icon
Boundless Bio's tech stack includes SalesforceMySQLMicrosoft ExcelFont AwesomeGoogle Cloud PlatformSAP Maintenance, Repair, and OverhaulMicrosoft AzureC++.

What is Boundless Bio's email format?

Minus sign iconPlus sign icon
Boundless Bio's email format typically follows the pattern of FLast@boundlessbio.com. Find more Boundless Bio email formats with LeadIQ.

How much funding has Boundless Bio raised to date?

Minus sign iconPlus sign icon
As of March 2026, Boundless Bio has raised $100M in funding. The last funding round occurred on May 16, 2023 for $100M.

When was Boundless Bio founded?

Minus sign iconPlus sign icon
Boundless Bio was founded in 2019.

Boundless Bio

Biotechnology ResearchCalifornia, United States11-50 Employees

Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.

When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes,  driving cancer cells to grow and allowing them to resist treatment.  At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive.

Our Culture:

At Boundless, you’ll experience what it means to be out in front of the wave. 
Our unprecedented science takes us to new shores, and our team navigates the best breaks. We’re leaders in our field, and we’re dedicated to the cause of understanding and treating intractable cancers.

Every employee at Boundless makes an unbridled impact on our capabilities and our culture. We’ll help you expand your abilities and defy your bounds by providing meaningful work and unbounded opportunities. Career development is essential at Boundless. 

We’re all in on this fight against cancer– collaboration is requisite to our success. We have a team of people who ask, offer, and accept help without regard for ego. We know that receiving support is energizing, and giving help is fulfilling. We are inspired by the patients who are reliant upon our success. 

At Boundless, we’re all in. We are unbound by convention, bound to save lives. 


Career Inquiries
careers@boundlessbio.com

General Information Inquiries
info@boundlessbio.com

Section iconCompany Overview

Headquarters
10955 Alexandria Way Suite 100 San Diego, California United States
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BOLD
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $100M

    Boundless Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $100M.

  • $25M$50M

    Boundless Bio's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $100M

    Boundless Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $100M.

  • $25M$50M

    Boundless Bio's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.